Williams Sanders Father of Ex-Lions RB Barry Sanders Dies of Lymphoma

William Sanders, father of legendary Detroit Lions running back Barry Sanders, died on Wednesday of symptoms caused by lymphoma. He was 74 years old.

The elder Sanders was diagnosed with lymphoma back in March and has dealt with the accompanying side-effects of treatment since then. Still, despite everything, William maintained his admirable positivity and spirit through it all.

Always close with his father, Barry spoke fondly of him during his 2004 Hall of Fame Speech. In a particularly memorable sequence, he recalled a bit of advice that his father gave to him after a junior varsity football game in which he didn’t catch punts because he was afraid of dropping them and losing the game.

"He said, 'Son, you can play the game the way it's supposed to be played. Don't be scared to make mistakes,' " Barry Sanders recalled. "'In life you're going to make some mistakes. Even if you wanted to stay in bed all day and avoid the world, that's not the answer, especially in the game of football. You're going to make some mistakes. Go out and play the way you're capable of, the coach has you in there for a reason, he has confidence in you."

The elder Sanders leaves behind 11 children and 16 grandchildren.

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap